These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia. Granoff AB J Adolesc Health Care; 1981 Sep; 2(1):23-7. PubMed ID: 7333940 [TBL] [Abstract][Full Text] [Related]
6. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH. Givens JR; Andersen RN; Ragland JB; Wiser WL; Umstot ES J Clin Endocrinol Metab; 1975 Jun; 40(6):988-1000. PubMed ID: 166091 [TBL] [Abstract][Full Text] [Related]
7. 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. Azziz R; Zacur HA J Clin Endocrinol Metab; 1989 Sep; 69(3):577-84. PubMed ID: 2547827 [TBL] [Abstract][Full Text] [Related]
8. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease. Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066 [TBL] [Abstract][Full Text] [Related]
9. Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia. Strott CA; Yoshimi T; Lipsett MB J Clin Invest; 1969 May; 48(5):930-9. PubMed ID: 4305376 [TBL] [Abstract][Full Text] [Related]
10. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment]. Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402 [TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia. Chang YT; Kulin HE; Garibaldi L; Suriano MJ; Bracki K; Pang S J Clin Endocrinol Metab; 1993 Nov; 77(5):1251-7. PubMed ID: 8077318 [TBL] [Abstract][Full Text] [Related]
12. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion. Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467 [TBL] [Abstract][Full Text] [Related]
13. [Partial deficiency in 21-hydroxylase in certain forms of hirsutism]. Lucisano A; Satta MA; Tripodi R; Mobili L; De Cicco F; Monaco F; Dell'Acqua S; Roche J C R Seances Soc Biol Fil; 1989; 183(2):117-21. PubMed ID: 2555033 [TBL] [Abstract][Full Text] [Related]
14. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization. Sólyom J; Gács G; Keszei K; Láng K; Orley J; Petheö I; Ságodi L Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770 [TBL] [Abstract][Full Text] [Related]
15. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies. Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672 [TBL] [Abstract][Full Text] [Related]
16. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency. Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498 [TBL] [Abstract][Full Text] [Related]
17. Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. Feldman S; Billaud L; Thalabard JC; Raux-Demay MC; Mowszowicz I; Kuttenn F; Mauvais-Jarvis P J Clin Endocrinol Metab; 1992 Mar; 74(3):635-9. PubMed ID: 1310999 [TBL] [Abstract][Full Text] [Related]
18. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia. Horrocks PM; London DR Clin Endocrinol (Oxf); 1982 Dec; 17(6):547-56. PubMed ID: 6299623 [TBL] [Abstract][Full Text] [Related]
19. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974 [TBL] [Abstract][Full Text] [Related]
20. Failure of angiotensin II to stimulate increases in concentrations of adrenal androgens, 17-hydroxyprogesterone, or adrenocorticotropin in congenital 21-hydroxylase deficiency. Wisgerhof M; Mellinger RC; Zafar MS J Clin Endocrinol Metab; 1983 Mar; 56(3):627-31. PubMed ID: 6296191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]